Transcatheter Aortic Valve-in-Surgical Aortic Valve (TAV-in-SAV) for bioprosthetic valve dysfunction after modified bentall’s procedure: A case report.
- Author:
Monica B. ALAGON
1
;
Jessielyn SIA
1
;
Timothy DY
1
;
Aristides PANLILIO
1
;
Nelson LEE
1
Author Information
- Publication Type:Case Report
- MeSH: Human; Male; Middle Aged: 45-64 Yrs Old; World Health Organization; Vital Signs; Respiratory Sounds; Research Report; Physical Examination; Constriction, Pathologic; Aortic Valve Stenosis
- From: Philippine Journal of Cardiology 2026;54(S1):24-29
- CountryPhilippines
-
Abstract:
This is the case of a 62-year-old male with prior modified Bentall’s procedure using a 23-mm bioprosthetic valve last 2013 who came in with progressive heart failure symptoms. On physical examination, vital signs are stable. Physical exam revealed rhonchi on both lung fields and irregular rhythm with a grade 3 systolic ejection murmur at the aortic area. A 2-dimensional transthoracic echocardiogram showed an ejection fraction of 25%, aortic valve area of 1.0 cm2 and mean gradient of 21 mmHg consistent with severe low-flow, low-gradient aortic stenosis (AS). Options for re-do surgical aortic valve replacement (SAVR) were discussed. Since the patient was deemed high risk for another surgery, the option for transcatheter aortic valve in surgical aortic valve (TAV-in-SAV) was considered. The patient underwent successful TAV-in-SAV using a 26-mm self-expanding bioprosthetic valve. Post-procedure, there was significant improvement of functional capacity from class IV to class I.
